TerminatedNot applicableNCT00176930
Stem Cell Transplant for Hematological Malignancy
Studying Juvenile myelomonocytic leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Principal Investigator
- Daniel Weisdorf, MDMasonic Cancer Center, University of Minnesota
- Intervention
- Stem Cell Transplant(biological)
- Enrollment
- 330 enrolled
- Eligibility
- 55 years · All sexes
- Timeline
- 2001 – 2019
Study locations (1)
- Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00176930 on ClinicalTrials.govOther trials for Juvenile myelomonocytic leukemia
Additional recruiting or active studies for the same condition.